{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:30:49Z","timestamp":1761611449937,"version":"3.37.3"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T00:00:00Z","timestamp":1528329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T00:00:00Z","timestamp":1528329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Rheumatoid arthritis (RA) is a systemic autoimmune disease including synovitis and synovial hyperplasia that contribute to joint destruction. Pivotal pathogenic mechanisms in this process are the dysregulated proliferation and apoptosis of fibroblast-like synoviocytes (FLS). Unfortunately, the mechanisms of FLS dysregulation are not completely elucidated. Here, we explored a new hypothesis based in the potent anti-proliferative and pro-apoptotic activity of retinoids in some types of cancer. Specifically, we investigated the role of retinoids and of the retinoic acid binding proteins, CRABP2 and FABP5, on the proliferation and apoptosis of FLS from RA by adding all-trans retinoic acid (ATRA) or silencing CRABP2 and FABP5. We showed an unconventional behaviour of RA FLS, which were relatively insensitive to ATRA. In effect, ATRA increased the resistance to apoptosis despite the high CRABP2\/FABP5 ratio of RA FLS; and<jats:italic>CRABP2<\/jats:italic>suppression sensitized RA FLS to Fas-induced apoptosis. This latter effect was associated with changes in expression of kinases,<jats:italic>ASK1<\/jats:italic>up-regulation and<jats:italic>ERK<\/jats:italic>down-regulation, and increased phosphorylation of JNK. In addition, the potentiation of FLS apoptosis by CRABP2 silencing persisted in the presence of pro-inflammatory mediators, TNF e IL1\u03b2. Therefore, the results point to CRABP2 as a potential target to decrease synovial hyperplasia in RA.<\/jats:p>","DOI":"10.1038\/s41598-018-26027-x","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T13:37:57Z","timestamp":1527860277000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Uncovering Cellular retinoic acid-binding protein 2 as a potential target for rheumatoid arthritis synovial hyperplasia"],"prefix":"10.1038","volume":"8","author":[{"given":"Nerea","family":"Mosquera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Rodriguez-Trillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Mera-Varela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2624-0606","authenticated-orcid":false,"given":"Antonio","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Conde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,7]]},"reference":[{"issue":"23","key":"26027_CR1","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes, I. B. & Schett, G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365(23), 2205\u20132219 (2011).","journal-title":"N. Engl. J. Med."},{"key":"26027_CR2","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S0140-6736(09)60008-8","volume":"373","author":"L Klareskog","year":"2009","unstructured":"Klareskog, L., Catrina, A. I. & Paget, S. Rheumatoid Arthritis. Lancet 373, 659\u2013672 (2009).","journal-title":"Lancet"},{"issue":"2","key":"26027_CR3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","volume":"46","author":"GS Firestein","year":"2017","unstructured":"Firestein, G. S. & McInnes, I. B. Immunopathogenesis of Rheumatoid Arthritis. Immunity 46(2), 183\u2013196 (2017).","journal-title":"Immunity"},{"issue":"4","key":"26027_CR4","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s10495-009-0317-y","volume":"14","author":"A Korb","year":"2009","unstructured":"Korb, A., Pavenst\u00e4dt, H. & Pap, T. Cell death in rheumatoid arthritis. Apoptosis 14(4), 447\u201354 (2009).","journal-title":"Apoptosis"},{"key":"26027_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/art.1780380405","volume":"38","author":"T Nakajima","year":"1995","unstructured":"Nakajima, T. et al. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum. 38, 485\u2013491 (1995).","journal-title":"Arthritis Rheum."},{"issue":"3","key":"26027_CR6","first-page":"430","volume":"24","author":"H Asahara","year":"1997","unstructured":"Asahara, H. et al. Expression of Fas antigen and Fas ligand in the rheumatoid synovial tissue. J. Rheumatol. 24(3), 430\u2013435 (1997).","journal-title":"J. Rheumatol."},{"issue":"204","key":"26027_CR7","first-page":"ar2370","volume":"10","author":"AK Andersson","year":"2008","unstructured":"Andersson, A. K., Li, C. & Brennan, F. M. Recent developments in the immunobiology of rheumatoid arthritis. Arthritis Res. Ther. 10(204), ar2370 (2008).","journal-title":"Arthritis Res. Ther."},{"key":"26027_CR8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1600-065X.2008.00648.x","volume":"223","author":"EH Noss","year":"2008","unstructured":"Noss, E. H. & Brenner, M. B. The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis. Immunol. Rev. 223, 252\u2013270 (2008).","journal-title":"Immunol. Rev."},{"key":"26027_CR9","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/rheumatology\/kel065","volume":"45","author":"LC Huber","year":"2006","unstructured":"Huber, L. C. et al. Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology (Oxford) 45, 669\u2013675 (2006).","journal-title":"Rheumatology (Oxford)"},{"key":"26027_CR10","doi-asserted-by":"crossref","unstructured":"Chen, Y. F. et al. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. Health Technol. Assess. 10(42), iii\u2013iv, xi\u2013xiii, 1\u2013229 (2006).","DOI":"10.3310\/hta10420"},{"issue":"Suppl 1","key":"26027_CR11","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/ar2666","volume":"11","author":"A Rubbert-Roth","year":"2009","unstructured":"Rubbert-Roth, A. & Finckh, A. Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review. Arthritis Res. Ther. 11(Suppl 1), S1 (2009).","journal-title":"Arthritis Res. Ther."},{"key":"26027_CR12","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1194\/jlr.R030833","volume":"54","author":"Z Al Tanoury","year":"2013","unstructured":"Al Tanoury, Z., Piskunov, A. & Rochette-Egly, C. Vitamin A and retinoid signaling: genomic and nongenomic effects. J. Lipid Res. 54, 1761\u20131775 (2013).","journal-title":"J. Lipid Res."},{"key":"26027_CR13","first-page":"006","volume":"S7","author":"KM Coyle","year":"2013","unstructured":"Coyle, K. M., Sultan, M., Thomas, M. L., Vaghar-Kashani, A. & Marcato P. Retinoid signaling in cancer and its promise for therapy. J Carcinog. Mutagen. S7, 006 (2013).","journal-title":"J Carcinog. Mutagen."},{"key":"26027_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/35106036","volume":"1","author":"L Altucci","year":"2001","unstructured":"Altucci, L. & Gronemeyer, H. The promise of retinoids to fight against cancer. Nat. Rev.Cancer 1, 181\u2013193 (2001).","journal-title":"Nat. Rev.Cancer"},{"key":"26027_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1146\/annurev.nutr.24.012003.132407","volume":"24","author":"DR Soprano","year":"2004","unstructured":"Soprano, D. R., Qin, P. & Soprano, K. J. Retinoic acid receptors and cancers. Annu. Rev. Nutr. 24, 201\u2013221 (2004).","journal-title":"Annu. Rev. Nutr."},{"issue":"5","key":"26027_CR16","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1684\/ejd.2015.2544","volume":"25","author":"L Beckenbach","year":"2015","unstructured":"Beckenbach, L., Baron, J. M., Merk, H. F., L\u00f6ffler, H. & Amann, P. M. Retinoid treatment of skin diseases. Eur. J. Dermatol. 25(5), 384\u201391 (2015).","journal-title":"Eur. J. Dermatol."},{"issue":"4","key":"26027_CR17","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1172\/JCI115438","volume":"88","author":"L Massacesi","year":"1991","unstructured":"Massacesi, L. et al. Immunosuppressive activity of 13-cis-retinoic acid and prevention of experimental autoimmune encephalomyelitis in rats. J. Clin. Invest. 88(4), 1331\u20137 (1991).","journal-title":"J. Clin. Invest."},{"issue":"3","key":"26027_CR18","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1111\/j.1523-1755.2004.00850.x","volume":"66","author":"G Perez de Lema","year":"2004","unstructured":"Perez de Lema, G. et al. Retinoic acid treatment protects MRL\/lpr lupus mice from the development of glomerular disease. Kidney Int 66(3), 1018\u20131028 (2004).","journal-title":"Kidney Int"},{"key":"26027_CR19","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.4049\/jimmunol.1102706","volume":"189","author":"S-K Kwok","year":"2012","unstructured":"Kwok, S.-K. et al. Retinoic acid attenuates rheumatoid inflammation in mice. J. Immunol. 189, 1062\u20131071 (2012).","journal-title":"J. Immunol."},{"key":"26027_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0014-5793(95)01440-3","volume":"378","author":"K Kuwabara","year":"1996","unstructured":"Kuwabara, K., Shudo, K. & Hori, Y. Novel synthetic retinoic acid inhibits rat collagen arthritis and differentially affects serum immunoglobulin subclass levels. FEBS Letters 378, 153\u2013156 (1996).","journal-title":"FEBS Letters"},{"key":"26027_CR21","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.4049\/jimmunol.129.6.2668","volume":"129","author":"DE Trentham","year":"1982","unstructured":"Trentham, D. E. & Brinckerhoff, C. E. Augmentation of collagen arthritis by synthetic analogues of retinoic acid. J. Immunol. 129, 2668\u20132672 (1982).","journal-title":"J. Immunol."},{"key":"26027_CR22","first-page":"355","volume":"30","author":"B Beehler","year":"2003","unstructured":"Beehler, B. et al. Inhibition of disease progression by a novel receptor antagonist in animal models of arthritis. J. Rheumatol. 30, 355\u2013363 (2003).","journal-title":"J. Rheumatol."},{"issue":"18","key":"26027_CR23","doi-asserted-by":"publisher","first-page":"8193","DOI":"10.1158\/0008-5472.CAN-05-1177","volume":"65","author":"LJ Donato","year":"2005","unstructured":"Donato, L. J. & Noy, N. Suppression of mammary carcinoma growth by retinoic acid: proapoptotic genes are targets for retinoic acid receptor and cellular retinoic acid-binding protein II signaling. Cancer Res. 65(18), 8193\u20138199 (2005).","journal-title":"Cancer Res."},{"issue":"8","key":"26027_CR24","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1128\/MCB.22.8.2632-2641.2002","volume":"22","author":"AS Budhu","year":"2002","unstructured":"Budhu, A. S. & Noy, N. Direct channeling of retinoic acid between cellular retinoic acid-binding protein II and retinoic acid receptor sensitizes mammary carcinoma cells to retinoic acid-induced growth arrest. Mol. Cell. Biol. 22(8), 2632\u20132641 (2002).","journal-title":"Mol. Cell. Biol."},{"issue":"14","key":"26027_CR25","doi-asserted-by":"publisher","first-page":"5114","DOI":"10.1128\/MCB.22.14.5114-5127.2002","volume":"22","author":"NS Tan","year":"2002","unstructured":"Tan, N. S. et al. Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Mol. Cell. Biol. 22(14), 5114\u20135127 (2002).","journal-title":"Mol. Cell. Biol."},{"issue":"4","key":"26027_CR26","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.cell.2007.02.050","volume":"129","author":"TT Schug","year":"2007","unstructured":"Schug, T. T., Berry, D. C., Shaw, N. S., Travis, S. N. & Noy, N. Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell 129(4), 723\u2013733 (2007).","journal-title":"Cell"},{"issue":"21","key":"26027_CR27","doi-asserted-by":"publisher","first-page":"7546","DOI":"10.1073\/pnas.0709981105","volume":"105","author":"TT Schug","year":"2008","unstructured":"Schug, T. T. et al. Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPAR beta\/delta to RAR. Proc. Natl. Acad. Sci. USA 105(21), 7546\u20137551 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"26027_CR28","doi-asserted-by":"publisher","first-page":"R224","DOI":"10.1186\/ar3211","volume":"12","author":"S Garc\u00eda","year":"2010","unstructured":"Garc\u00eda, S., Forteza, J., L\u00f3pez-Otin, C., G\u00f3mez-Reino, J. J. & Gonz\u00e1lez, A. Matrix metalloproteinase-8 deficiency increases joint inflammation and bone erosion in the K\/BxN serum-transfer arthritis model. Arthritis Res. Ther. 12, R224 (2010).","journal-title":"Arthritis Res. Ther."},{"issue":"7","key":"26027_CR29","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/art.27470","volume":"67","author":"JP Jacobs","year":"2010","unstructured":"Jacobs, J. P. et al. Deficiency of CXCR2, but not other chemokine receptors, attenuates autoantibody-mediated arthritis in a murine model. Arthritis Rheum. 67(7), 1921\u20131932 (2010).","journal-title":"Arthritis Rheum."},{"key":"26027_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1053\/j.seminoncol.2015.09.002","volume":"43","author":"IP Uray","year":"2016","unstructured":"Uray, I. P., Dimitrovsky, E. & Brown, P. H. Retinoids and rexinoids in cancer prevention: from laboratory to clinic. Seminars Oncol. 43, 49\u201364 (2016).","journal-title":"Seminars Oncol."},{"key":"26027_CR31","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.ctrv.2014.01.001","volume":"40","author":"E Garattini","year":"2014","unstructured":"Garattini, E. et al. Retinoids and breast cancer: From basic studies to the clinic and back again. Cancer Treat. Rev. 40, 739\u2013749 (2014).","journal-title":"Cancer Treat. Rev."},{"key":"26027_CR32","unstructured":"Coyle, K. M., Sultan, M., Thomas, M. L., Vaghar-Kashani, A. & Marcato, P. Retinoid signaling in cancer and its promise for therapy. J. Carcinog. Mutagen. S7 (2013)."},{"key":"26027_CR33","doi-asserted-by":"publisher","first-page":"950","DOI":"10.15252\/emmm.201404670","volume":"7","author":"F Centritto","year":"2015","unstructured":"Centritto, F. et al. Cellular and molecular determinants of all-trans retinoic acid sensitivity in breast cancer: Luminal phenotype and RAR\u03b1 expression. EMBO Mol. Med. 7, 950\u2013972 (2015).","journal-title":"EMBO Mol. Med."},{"key":"26027_CR34","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/glia.22946","volume":"64","author":"R-Z Liu","year":"2016","unstructured":"Liu, R.-Z. et al. Association between cytoplasmic CRABP2, altered retinoic acid signaling, and poor prognosis in glioblastoma. Glia 64, 963\u2013976 (2016).","journal-title":"Glia"},{"key":"26027_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-015-0380-7","volume":"14","author":"R-Z Liu","year":"2015","unstructured":"Liu, R.-Z. et al. CRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acid. Mol. Cancer 14, 129 (2015).","journal-title":"Mol. Cancer"},{"issue":"3","key":"26027_CR36","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1189\/jlb.1107790","volume":"85","author":"N Engedal","year":"2009","unstructured":"Engedal, N., Auberger, P. & Blomhoff, H. K. Retinoic acid regulates Fas-induced apoptosis in Jurkat T cells: reversal of mitogen-mediated repression of Fas DISC assembly. J Leukoc Biol 85(3), 469\u201380 (2009).","journal-title":"J Leukoc Biol"},{"key":"26027_CR37","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1002\/1521-4141(200105)31:5<1382::AID-IMMU1382>3.0.CO;2-Y","volume":"31","author":"R Toth","year":"2001","unstructured":"Toth, R. et al. Activation-induced apoptosis and cell surface expression of Fas (CD95) ligand are reciprocally regulated by retinoic acid receptor \u03b1 and \u03b3 and involve nur77 in T cells. Eur, J. Immunol. 31, 1382\u20131391 (2001).","journal-title":"Eur, J. Immunol."},{"issue":"10","key":"26027_CR38","doi-asserted-by":"publisher","first-page":"5576","DOI":"10.1128\/MCB.15.10.5576","volume":"15","author":"RP Bissonnette","year":"1995","unstructured":"Bissonnette, R. P. et al. 9-cis retinoic acid inhibition of activation-induced apoptosis is mediated via regulation of fas ligand and requires retinoic acid receptor and retinoid X receptor activation. Mol. Cell. Biol. 15(10), 5576\u20135585 (1995).","journal-title":"Mol. Cell. Biol."},{"issue":"8","key":"26027_CR39","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.18632\/oncotarget.3334","volume":"6","author":"S-L Xia","year":"2015","unstructured":"Xia, S.-L. et al. CRABP-II and FABP5 independent responsiveness of human glioblastoma cells to all-trans retinoic acid. Oncotarget 6(8), 5889\u20135902 (2015).","journal-title":"Oncotarget"},{"key":"26027_CR40","doi-asserted-by":"publisher","first-page":"8193","DOI":"10.1158\/0008-5472.CAN-05-1177","volume":"65","author":"LJ Donato","year":"2005","unstructured":"Donato, L. J. & Noy, N. Suppression of Mammary Carcinoma Growth by Retinoic Acid: Proapoptotic Genes Are Targets for Retinoic Acid Receptor and Cellular Retinoic Acid\u2013Binding Protein II Signaling. Cancer Res. 65, 8193\u20138199 (2005).","journal-title":"Cancer Res."},{"issue":"48","key":"26027_CR41","doi-asserted-by":"publisher","first-page":"6245","DOI":"10.1038\/onc.2008.301","volume":"27","author":"DN Dhanasekaran","year":"2008","unstructured":"Dhanasekaran, D. N. & Reddy, E. P. JNK signaling in apoptosis. Oncogene 27(48), 6245\u20136251 (2008).","journal-title":"Oncogene"},{"issue":"5296","key":"26027_CR42","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1126\/science.275.5296.90","volume":"275","author":"H Ichijo","year":"1997","unstructured":"Ichijo, H. et al. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK\/JNK and p38 signaling pathways. Science 275(5296), 90\u201394 (1997).","journal-title":"Science"},{"issue":"3","key":"26027_CR43","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S1097-2765(00)80283-X","volume":"2","author":"H Nishitoh","year":"1998","unstructured":"Nishitoh, H. et al. ASK1 is essential for JNK\/SAPK activation by TRAF2. Mol. Cell 2(3), 389\u2013395 (1998).","journal-title":"Mol. Cell"},{"key":"26027_CR44","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1186\/ar2941","volume":"12","author":"S Garc\u00eda","year":"2010","unstructured":"Garc\u00eda, S., Liz, M., G\u00f3mez-Reino, J. J. & Conde, C. Akt activity protects rheumatoid synovial fibroblasts from Fas-induced apoptosis by inhibition of Bid cleavage. Arthritis Res Ther 12, R33 (2010).","journal-title":"Arthritis Res Ther"},{"key":"26027_CR45","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/rheumatology\/keh039","volume":"43","author":"K Itoh","year":"2004","unstructured":"Itoh, K., Hase, H., Kojima, H., Saotome, K. & Nishioka, K. Central role of mitocondria and p53 in Fas-mediated apoptosis of rheumatoid sinovial fibroblasts. Rheumatology 43, 277\u2013285 (2004).","journal-title":"Rheumatology"},{"issue":"19","key":"26027_CR46","doi-asserted-by":"publisher","first-page":"16484","DOI":"10.1074\/jbc.M010384200","volume":"276","author":"SE Tran","year":"2001","unstructured":"Tran, S. E., Holmstr\u00f6m, T. H., Ahonen, M., K\u00e4h\u00e4ri, V.-M. & Eriksson, J. E. MAPK\/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors. J. Biol. Chem. 276(19), 16484\u201316490 (2001).","journal-title":"J. Biol. Chem."},{"issue":"29","key":"26027_CR47","doi-asserted-by":"publisher","first-page":"5418","DOI":"10.1093\/emboj\/19.20.5418","volume":"19","author":"TH Holmstr\u00f6m","year":"2000","unstructured":"Holmstr\u00f6m, T. H. et al. MAPK\/ERK signaling in activated T cells inhibits CD95\/Fas-mediated apoptosis downstream of DISC assembly. EMBO J. 19(29), 5418\u20135428 (2000).","journal-title":"EMBO J."},{"issue":"8","key":"26027_CR48","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1002\/art.34443","volume":"64","author":"B Orosa","year":"2012","unstructured":"Orosa, B., Gonzalez, A., Mera, A., G\u00f3mez-Reino, J. J. & Conde, C. Lysophosphatidic acid receptor 1 suppression sensitizes rheumatoid fibroblast-like synoviocytes to TNF-induced apoptosis. Arthritis Rheum. 64(8), 2460\u201370 (2012).","journal-title":"Arthritis Rheum."},{"issue":"1","key":"26027_CR49","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","volume":"233","author":"B Bartok","year":"2010","unstructured":"Bartok, B. & Firestein, G. S. Fibroblast-like synoviocytes: key efector cells in rheumatoid arthritis. Immunol. Rev. 233(1), 233\u2013255 (2010).","journal-title":"Immunol. Rev."},{"key":"26027_CR50","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/ard.2007.077040","volume":"67","author":"S Garcia","year":"2008","unstructured":"Garcia, S., Boda\u00f1o, A., Pablos, J. L., Gomez-Reino, J. J. & Conde, C. Poly(ADP-ribose) polymerase inhibition reduces tumor necrosis factor-induced inflammatory response in rheumatoid sinovial fibroblasts. Ann. Rheum. Dis. 67, 631\u2013637 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"26027_CR51","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.lfs.2014.12.008","volume":"122","author":"S Hong","year":"2015","unstructured":"Hong, S. et al. TNF-\u03b1 confers resistance to Fas-mediated apoptosis in rheumatoid arthritis through the induction of soluble Fas. Life Sci. 122, 37\u201341 (2015).","journal-title":"Life Sci."},{"key":"26027_CR52","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1365-2249.2006.03070.x","volume":"144","author":"W-U Kim","year":"2006","unstructured":"Kim, W.-U. et al. Hydroxychloroquine potentiates Fas-mediated apoptosis of rheumatoid synoviocytes. Clin. Exp. Immunol. 144, 503\u2013511 (2006).","journal-title":"Clin. Exp. Immunol."},{"key":"26027_CR53","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/rheumatology\/kei113","volume":"45","author":"SL Peng","year":"2006","unstructured":"Peng, S. L. Fas(CD95)-related apoptosis and rheumatoid arthritis. Rheumatology 45, 26\u201330 (2006).","journal-title":"Rheumatology"},{"key":"26027_CR54","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1987","unstructured":"Arnett, F. C. et al. The American Rheumatism association1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31, 315\u2013324 (1987).","journal-title":"Arthritis Rheum"},{"issue":"49","key":"26027_CR55","doi-asserted-by":"publisher","first-page":"34065","DOI":"10.1074\/jbc.M114.604041","volume":"289","author":"AC Vreeland","year":"2014","unstructured":"Vreeland, A. C., Levi, L., Zhang, W., Berry, D. C. & Noy, N. Cellular retinoic acid-binding protein 2 inhibits tumor growth by two distinct mechanisms. J. Biol. Chem. 289(49), 34065\u201373 (2014).","journal-title":"J. Biol. Chem."},{"issue":"7","key":"26027_CR56","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.ajpath.2017.02.021","volume":"187","author":"S Fischer-Huchzermeyer","year":"2017","unstructured":"Fischer-Huchzermeyer, S. et al. The celular retinoic acid binding protein 2 promotes survival of maligant peripheral nerve sheat tumor cells. Am. J. Pathol. 187(7), 1623\u20131632 (2017).","journal-title":"Am. J. Pathol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26027-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26027-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26027-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T06:56:11Z","timestamp":1720335371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-26027-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,7]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["26027"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-26027-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2018,6,7]]},"assertion":[{"value":"19 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8731"}}